Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,136 | -13,536 | -58,573 | -59,974 | -40,937 |
| Depreciation Amortization | 539 | 289 | 935 | 830 | 581 |
| Accounts receivable | 19,501 | 10,954 | -24,848 | -53 | -1,726 |
| Accounts payable and accrued liabilities | -2,268 | -1,213 | 3,788 | -999 | -1,585 |
| Other Working Capital | 16,125 | 6,068 | -29,049 | -1,227 | -4,219 |
| Other Operating Activity | -11,905 | -6,636 | 33,989 | 9,574 | 9,338 |
| Operating Cash Flow | $1,856 | $-4,074 | $-73,758 | $-51,849 | $-38,548 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,620 | 15,650 | 72,334 | 54,013 | 43,648 |
| PPE Investments | 127 | 127 | 443 | 166 | 76 |
| Purchase Sale Intangibles | -15,000 | -15,000 | N/A | 0 | 0 |
| Other Investing Activity | -15,000 | -15,000 | 0 | 0 | 0 |
| Investing Cash Flow | $3,747 | $777 | $72,777 | $54,179 | $43,724 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,950 | 19,950 | 19,542 | 19,542 | 9,942 |
| Common Stock Issued | 554 | 1 | 2,124 | 1,539 | 1,539 |
| Other Financing Activity | -1,754 | -828 | -15,116 | -12,435 | -8,346 |
| Financing Cash Flow | $18,750 | $19,123 | $6,550 | $8,646 | $3,135 |
| Beginning Cash Position | 24,459 | 24,459 | 18,890 | 18,890 | 18,890 |
| End Cash Position | 48,812 | 40,285 | 24,459 | 29,866 | 27,201 |
| Net Cash Flow | $24,353 | $15,826 | $5,569 | $10,976 | $8,311 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,856 | -4,074 | -73,758 | -51,849 | -38,548 |
| Capital Expenditure | N/A | N/A | -450 | -377 | -188 |
| Free Cash Flow | 1,856 | -4,074 | -74,208 | -52,226 | -38,736 |